Back to Search
LAURA DOOLEY, M.D.
M.D.
Family Medicine Physician
NPI: 1437252566Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
5574(AK)A84007(CA)
Research & Publications (20)
How to improve postgenomic knowledge discovery using imputation.
PMID 19223972·EURASIP J Bioinform Syst Biol·2009
8-other
The midwife I want to be. First place winning entry.
PMID 19627071·Midwifery Today Int Midwife·2009
8-other
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
PMID 18486740·Lancet·2008
3-trial
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
PMID 18486739·Lancet·2008
3-trial
Ameliorative missing value imputation for robust biological knowledge inference.
PMID 18334307·J Biomed Inform·2008
8-other
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
PMID 18627375·Br J Dermatol·2008
4-observational
Resection of a post-traumatic hemangioma of the forehead: benefits and pitfalls of an endoscopic resection.
PMID 18800321·Ear Nose Throat J·2008
5-case
Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review.
PMID 18042961·BMJ·2008
1-meta
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.
PMID 17114188·Ann Rheum Dis·2007
3-trial
Interventions for the interruption or reduction of the spread of respiratory viruses.
PMID 17943895·Cochrane Database Syst Rev·2007
1-meta
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.
PMID 17665424·Arthritis Rheum·2007
3-trial
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
PMID 17287478·N Engl J Med·2007
3-trial
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
PMID 17097378·J Am Acad Dermatol·2007
4-observational
Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis.
PMID 16960923·J Rheumatol·2006
2-rct
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
PMID 16704649·Br J Dermatol·2006
3-trial
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis.
PMID 16096330·Ann Rheum Dis·2006
3-trial
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.
PMID 15677701·Ann Rheum Dis·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 329 BENNET STREET
WRANGELL, AK 99929 - Phone
- (907) 874-4700
Quick Facts
- NPI
- 1437252566
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile